Shetty Reshma P.'s Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed Nov 25, 2022
- Accession no.
- 0000899243-22-037050
- Filed
- Nov 25, 2022
- Trade date
- Nov 22-23, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $812.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shetty Reshma P.CIK 0001873523 | Director, Officer (See remarks), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 | Class A Common Stock | SSaleDisposed | −101,813 | $2.04 | −$207,698.52 | 20,418,090 | Direct | Duplicate filing |
| Nov 22, 2022 | Class A Common Stock | SSaleDisposed | −101,813 | $2.04 | −$207,698.52 | 20,418,091 | Indirect | Duplicate filing |
| Nov 23, 2022 | Class A Common Stock | SSaleDisposed | −99,798 | $1.99 | −$198,598.02 | 20,318,292 | Direct | Duplicate filing |
| Nov 23, 2022 | Class A Common Stock | SSaleDisposed | −99,797 | $1.99 | −$198,596.03 | 20,318,294 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
President, COO & Founder